Építés alatt – nem éles oldal
Belépés

IgA-nefropátia trials, also abroad

93 open IgA-nefropátia trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Kína53
Egyesült Államok27
Spanyolország12
Franciaország12
Egyesült Királyság12
All other countries

The same trial often runs in several countries

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy has 1 site in Chile and runs in 36 countries. If a site near you is full, another one may still take people.

See A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy in all 36 countries
Építés alatt, nem éles – IgA-nefropátia: vizsgálatok itt: Chile – Frontlight Research